Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

被引：0
|
作者：
Kara N. Maxwell
Danielle Soucier-Ernst
Emin Tahirovic
Andrea B. Troxel
Candace Clark
Michael Feldman
Christopher Colameco
Bijal Kakrecha
Melissa Langer
David Lieberman
Jennifer J. D. Morrissette
Matt R. Paul
Tien-chi Pan
Stephanie Yee
Natalie Shih
Erica Carpenter
Lewis A. Chodosh
Angela DeMichele
机构：
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Medicine, Division of Hematology
[2] Perelman School of Medicine at the University of Pennsylvania,Oncology
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology
[5] Perelman School of Medicine at the University of Pennsylvania,Department of Pathology and Laboratory Medicine
[6] Diabetes and Metabolism at the Perelman School of Medicine at the University of Pennsylvania,Department of Cancer Biology
[7] NYU School of Medicine,Department of Medicine, Division of Endocrinology
[8] University of Maryland School of Medicine,Department of Population Health
来源：
Breast Cancer Research and Treatment | 2017年 / 164卷
关键词：
Metastatic breast cancer; Liquid biopsy; Cell-free DNA; Genomic testing; Massively parallel sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 638
页数：11
相关论文
共 50 条
  • [1] Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
    Kara N. Maxwell
    Danielle Soucier-Ernst
    Emin Tahirovic
    Andrea B. Troxel
    Candace Clark
    Michael Feldman
    Christopher Colameco
    Bijal Kakrecha
    Melissa Langer
    David Lieberman
    Jennifer J. D. Morrissette
    Matt R. Paul
    Tien-chi Pan
    Stephanie Yee
    Natalie Shih
    Erica Carpenter
    Lewis A. Chodosh
    Angela DeMichele
    Breast Cancer Research and Treatment, 2017, 164 : 639 - 640
  • [2] Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer (vol 164, pg 627, 2017)
    Maxwell, Kara N.
    Soucier-Ernst, Danielle
    Tahirovic, Emin
    Troxel, Andrea B.
    Clark, Candace
    Feldman, Michael
    Colameco, Christopher
    Kakrecha, Bijal
    Langer, Melissa
    Lieberman, David
    Morrissette, Jennifer J. D.
    Paul, Matt R.
    Pan, Tien-chi
    Yee, Stephanie
    Shih, Natalie
    Carpenter, Erica
    Chodosh, Lewis A.
    DeMichele, Angela
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 639 - 640
  • [3] Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact
    Huebner, Hanna
    Wimberger, Pauline
    Laakmann, Elena
    Ruckhaeberle, Eugen
    Ruebner, Matthias
    Lehle, Sarah
    Uhrig, Sabrina
    Ziegler, Philipp
    Link, Theresa
    Hack, Carolin C.
    Belleville, Erik
    Faull, Iris
    Hausch, Marcus
    Wallwiener, Diethelm
    Schneeweiss, Andreas
    Tesch, Hans
    Brucker, Sara Y.
    Beckmann, Matthias W.
    Fasching, Peter A.
    Mueller, Volkmar
    Fehm, Tanja N.
    PRECISION CLINICAL MEDICINE, 2025, 8 (01)
  • [4] Concordance and use patterns of tissue and cell-free based genomic testing in metastatic breast cancer
    Liu, Minetta
    Schaffer, Jeff
    Piwowarczyk, Aneta
    Beaubier, Nike
    Blackwell, Kimberly
    Park, Ben
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Comparison of tumor genotyping and cell-free circulating tumor DNA sequencing in metastatic breast cancer patients and their utility in the selection of matched therapy
    Vidula, N.
    Juric, D.
    Niemierko, A.
    Spring, L.
    Moy, B.
    Malvarosa, G.
    Yuen, M.
    Habin, K.
    Shin, J.
    Peppercorn, J.
    Isakoff, S.
    Ellisen, L.
    Iafrate, A. J.
    Bardia, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [6] Genomic landscape of cell-free DNA in a diverse cohort of metastatic breast cancer patients.
    Cheng, Shirley
    Nguyen, Edward
    Pagano, Ian
    Fukui, Jami Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Circulating cell-free DNA and its clinical utility in cancer
    Salviano-Silva, Amanda
    Maire, Cecile L.
    Lamszus, Katrin
    Ricklefs, Franz L.
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (04) : 265 - 272
  • [8] Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer
    Kong, Say Li
    Liu, Xingliang
    Tan, Swee Jin
    Tai, Joyce A.
    Phua, Ler Yee
    Poh, Huay Mei
    Yeo, Trifanny
    Chua, Yong Wei
    Haw, Yu Xuan
    Ling, Wen Huan
    Ng, Raymond Chee Hui
    Tan, Tira J.
    Loh, Kiley Wei Jen
    Tan, Daniel Shao-Weng
    Ng, Quan Sing
    Ang, Mei Kim
    Toh, Chee Keong
    Lee, Yi Fang
    Lim, Chwee Teck
    Lim, Tony Kiat Hon
    Hillmer, Axel M.
    Yap, Yoon Sim
    Lim, Wan-Teck
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer
    Laufer-Geva, Smadar
    Rozenblum, Anna Belilovski
    Twito, Tal
    Grinberg, Roxana
    Dvir, Addie
    Soussan-Gutman, Lior
    Ilouze, Maya
    Roisman, Laila C.
    Dudnik, Elizabeth
    Zer, Alona
    Rotem, Ofer
    Lanman, Richard B.
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1705 - 1716
  • [10] Managing metastatic breast cancer via serial monitoring with circulating cell-free tumor DNA next generation sequencing testing
    Austin, Laura
    Nagy, Rebecca
    Zill, Oliver
    Lanman, Richard B.
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2016, 76
12345